Scynexis (SCYX) Depreciation & Amortization (CF) (2013 - 2023)
Scynexis (SCYX) reported Depreciation & Amortization (CF) of $129000.0 for Q4 2023, down 16.77% on a YoY basis from $155000.0 in Q4 2022, and down 12.24% quarter-over-quarter from $147000.0 in Q3 2023.
Scynexis (SCYX) Depreciation & Amortization (CF) (2013 - 2023) Analysis & Trends
Scynexis has reported Depreciation & Amortization (CF) for 11 years, with the latest figure at $129000.0 in Q4 2023.
- For the quarter ending Q4 2023, Depreciation & Amortization (CF) fell 16.77% year-over-year to $129000.0; the trailing twelve-month figure through Sep 2024 stood at $129000.0 (down 78.71% YoY), and the FY2023 full-year result was $580000.0, down 4.29% from the prior year.
- Depreciation & Amortization (CF) for Q4 2023 stood at $129000.0, down from $147000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $246000.0 in Q4 2021, with the low at $26000.0 in Q3 2019.
- Historically, Depreciation & Amortization (CF) has averaged $93800.0 across 5 years, with a median of $88000.0 in 2020.
- Annual changes were most pronounced in 2019 — Depreciation & Amortization (CF) soared 2900.0% — and 2022, when it sank 36.99%.
- Scynexis' Depreciation & Amortization (CF) stood at $26000.0 in 2019, then soared by 353.85% to $118000.0 in 2020, then surged by 108.47% to $246000.0 in 2021, then sank by 36.99% to $155000.0 in 2022, then slipped by 16.77% to $129000.0 in 2023.
- The last three Depreciation & Amortization (CF) figures came in at $129000.0 (Q4 2023), $147000.0 (Q3 2023), and $153000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 7.20 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 22.68 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 497,000.00 |
| 10 | Scynexis | 221.66 Mn | 162.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 129,000.00 |
| Dec 31, 2023 | 129,000.00 |
| Sep 30, 2023 | 147,000.00 |
| Sep 30, 2023 | 147,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Mar 31, 2023 | 151,000.00 |
| Mar 31, 2023 | 151,000.00 |
| Dec 31, 2022 | 155,000.00 |
| Dec 31, 2022 | 155,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 146,000.00 |
| Jun 30, 2022 | 146,000.00 |
| Mar 31, 2022 | 155,000.00 |
| Mar 31, 2022 | 155,000.00 |
| Dec 31, 2021 | 246,000.00 |
| Dec 31, 2021 | 246,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Sep 30, 2021 | 48,000.00 |